UM

Usama Maknojia Abdul Wahid

Active Director Director DIN 07691053
DIN 07691053 First appointment Feb 2017 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Usama Maknojia Abdul Wahid

Data last updated:

Usama Maknojia Abdul Wahid is a Director at Muqawwi Unani Medicine Remedies Private Limited (since 2017). The company operates in Healthcare.

DIN 07691053
Primary Designation Director
Industry Healthcare
First Appointment 13 Feb 2017
Oldest Company Age 9 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Feb 20172017Active

Board colleagues of Usama Maknojia Abdul Wahid

Directorship timeline

Open interactive timeline →
Muqawwi Unani Medicine Remedies Private Limited
Premium access

Shareholding and investment profile for Usama Maknojia Abdul Wahid

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Usama Maknojia Abdul Wahid

Usama Maknojia Abdul Wahid currently holds 1 directorship: Muqawwi Unani Medicine Remedies Private Limited (Director, since 13 Feb 2017).

Usama Maknojia Abdul Wahid was first appointed on 13 Feb 2017 as Director at Muqawwi Unani Medicine Remedies Private Limited.

The current boards of Usama Maknojia Abdul Wahid's companies include Abdulwahid Usman Maknojia (Muqawwi Unani Medicine Remedies Private Limited), Huzaifa Abdul Wahid Maknojia (Muqawwi Unani Medicine Remedies Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available